A NEW IMMUNOMODULATING COMPOUND (AS-101) WITH POTENTIAL THERAPEUTIC APPLICATION

被引:197
作者
SREDNI, B [1 ]
CASPI, RR [1 ]
KLEIN, A [1 ]
KALECHMAN, Y [1 ]
DANZIGER, Y [1 ]
BENYAAKOV, M [1 ]
TAMARI, T [1 ]
SHALIT, F [1 ]
ALBECK, M [1 ]
机构
[1] BAR ILAN UNIV,DEPT CHEM,IL-52100 RAMAT GAN,ISRAEL
关键词
D O I
10.1038/330173a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:173 / 176
页数:4
相关论文
共 37 条
[1]  
APTE RN, 1978, EXPT HEMATOLOGY TODA, P213
[2]   CLEARANCE RATES AND SYSTEMIC EFFECTS OF INTRAVENOUSLY ADMINISTERED INTERLEUKIN-2 (IL-2) CONTAINING PREPARATIONS IN HUMAN-SUBJECTS [J].
BINDON, C ;
CZERNIECKI, M ;
RUELL, P ;
EDWARDS, A ;
MCCARTHY, WH ;
HARRIS, R ;
HERSEY, P .
BRITISH JOURNAL OF CANCER, 1983, 47 (01) :123-133
[3]   GROWTH OF MOUSE BONE MARROW CELLS IN VITRO [J].
BRADLEY, TR ;
METCALF, D .
AUSTRALIAN JOURNAL OF EXPERIMENTAL BIOLOGY AND MEDICAL SCIENCE, 1966, 44 :287-&
[4]   MODULATION OF INTERLEUKIN-2 RELEASE FROM A PRIMATE LYMPHOID-CELL LINE IN SERUM-FREE AND SERUM-CONTAINING MEDIA [J].
BROWN, RL ;
GRIFFITH, RL ;
RUSCETTI, FW ;
RABIN, H .
CELLULAR IMMUNOLOGY, 1985, 92 (01) :14-21
[5]   TRANSIENT EXPRESSION OF INTERLEUKIN-2 RECEPTORS - CONSEQUENCES FOR T-CELL GROWTH [J].
CANTRELL, DA ;
SMITH, KA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (06) :1895-1911
[6]  
CHANG AE, 1984, J BIOL RESP MODIF, V3, P561
[7]   IMMUNOTHERAPEUTIC AGENTS - THEIR ROLE IN CELLULAR-IMMUNITY AND THEIR THERAPEUTIC POTENTIAL [J].
CHIRIGOS, MA ;
TALMADGE, JE .
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1985, 8 (04) :327-346
[8]   THE BIOCHEMISTRY, BIOLOGY, AND ROLE OF INTERLEUKIN-2 IN THE INDUCTION OF CYTO-TOXIC T-CELL AND ANTIBODY-FORMING B-CELL RESPONSES [J].
FARRAR, JJ ;
BENJAMIN, WR ;
HILFIKER, ML ;
HOWARD, M ;
FARRAR, WL ;
FULLERFARRAR, J .
IMMUNOLOGICAL REVIEWS, 1982, 63 :129-166
[9]  
FENICHEL RL, 1985, IMMUNE MODULATION AG, V25
[10]   ROLE OF MEMBRANE-POTENTIAL IN THE REGULATION OF LECTIN-INDUCED CALCIUM-UPTAKE [J].
GELFAND, EW ;
CHEUNG, RK ;
GRINSTEIN, S .
JOURNAL OF CELLULAR PHYSIOLOGY, 1984, 121 (03) :533-539